-
Je něco špatně v tomto záznamu ?
A biochemical approach to the anti-inflammatory, antioxidant and antiapoptotic potential of beta-carotene as a protective agent against bromobenzene-induced hepatotoxicity in female Wistar albino rats
Priya Josson Akkara, Evan Prince Sabina
Jazyk angličtina Země Česko
Typ dokumentu klinická studie
- MeSH
- beta-karoten * MeSH
- brombenzeny * otrava škodlivé účinky MeSH
- lékové postižení jater MeSH
- lidé MeSH
- ochranné látky MeSH
- potkani Wistar MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- klinická studie MeSH
Bromobenzene is a compound which has contributed much in understanding the mechanisms involved in xenobiotic hepatotoxicity induced by drugs and environment pollutants. In the present study, the protective and ameliorative effect of beta-carotene was investigated against bromobenzene-induced hepatotoxicity and compared with silymarin, a standard hepatoprotective reference drug. Beta-carotene (10 mg/kg b.w. p.o.) was administered to the rats for 9 days before intragastric intubation of bromobenzene (10 mmol/kg b.w.). Liver marker enzymes (aspartate transaminase, alanine transaminase and alkaline phosphatase), total protein content, bilirubin, total cholesterol, high-density lipoproteins, triglycerides, antioxidant status (reduced glutathione, superoxide dismutase, catalase, glutathione-S-transferase and glutathione peroxidase) were assessed along with histopathological analysis. ELISA was performed for analysing the levels of cytokines such as TNF-α, IL-1β and IL-6 in serum and in the liver. Caspase-3, COX-2 and NF-κB were evaluated by Western blotting. Administration of bromobenzene resulted in elevated levels of liver marker enzymes, bilirubin, lipid peroxidation and cytokines but deterioration in total protein content, antioxidant levels and histopathological conditions. Pre-treatment with beta-carotene not only significantly decreased the levels of liver markers, lipid peroxidation and cytokines but also improved histo-architecture and increased antioxidant levels minimising oxidative stress, and reduced factors contributing to apoptosis. This significant reversal of the biochemical changes on pre-treatment with beta-carotene in comparison with rats administered with bromobenzene clearly demonstrates that beta-carotene possesses promising hepatoprotective effect through its antioxidant, anti-inflammatory and antiapoptotic activity and hence is suggested as a potential therapeutic agent for protection from bromobenzene.
Kristu Jayanti College Bengaluru India
Vellore Institute of Technology School of Bio Sciences and Technology Vellore India
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20017294
- 003
- CZ-PrNML
- 005
- 20210428153242.0
- 007
- ta
- 008
- 201103s2020 xr ad f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.32725/jab.2020.011 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Akkara, Priya Josson $u Vellore Institute of Technology, School of Bio Sciences and Technology, Vellore, India; Kristu Jayanti College (Autonomous), Bengaluru, India
- 245 12
- $a A biochemical approach to the anti-inflammatory, antioxidant and antiapoptotic potential of beta-carotene as a protective agent against bromobenzene-induced hepatotoxicity in female Wistar albino rats / $c Priya Josson Akkara, Evan Prince Sabina
- 504 __
- $a Literatura
- 520 9_
- $a Bromobenzene is a compound which has contributed much in understanding the mechanisms involved in xenobiotic hepatotoxicity induced by drugs and environment pollutants. In the present study, the protective and ameliorative effect of beta-carotene was investigated against bromobenzene-induced hepatotoxicity and compared with silymarin, a standard hepatoprotective reference drug. Beta-carotene (10 mg/kg b.w. p.o.) was administered to the rats for 9 days before intragastric intubation of bromobenzene (10 mmol/kg b.w.). Liver marker enzymes (aspartate transaminase, alanine transaminase and alkaline phosphatase), total protein content, bilirubin, total cholesterol, high-density lipoproteins, triglycerides, antioxidant status (reduced glutathione, superoxide dismutase, catalase, glutathione-S-transferase and glutathione peroxidase) were assessed along with histopathological analysis. ELISA was performed for analysing the levels of cytokines such as TNF-α, IL-1β and IL-6 in serum and in the liver. Caspase-3, COX-2 and NF-κB were evaluated by Western blotting. Administration of bromobenzene resulted in elevated levels of liver marker enzymes, bilirubin, lipid peroxidation and cytokines but deterioration in total protein content, antioxidant levels and histopathological conditions. Pre-treatment with beta-carotene not only significantly decreased the levels of liver markers, lipid peroxidation and cytokines but also improved histo-architecture and increased antioxidant levels minimising oxidative stress, and reduced factors contributing to apoptosis. This significant reversal of the biochemical changes on pre-treatment with beta-carotene in comparison with rats administered with bromobenzene clearly demonstrates that beta-carotene possesses promising hepatoprotective effect through its antioxidant, anti-inflammatory and antiapoptotic activity and hence is suggested as a potential therapeutic agent for protection from bromobenzene.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a brombenzeny $x otrava $x škodlivé účinky $7 D001969
- 650 _2
- $a lékové postižení jater $7 D056486
- 650 _2
- $a ochranné látky $7 D020011
- 650 _2
- $a potkani Wistar $7 D017208
- 650 12
- $a beta-karoten $7 D019207
- 655 _2
- $a klinická studie $7 D000068397
- 700 1_
- $a Sabina, Evan Prince $u Vellore Institute of Technology, School of Bio Sciences and Technology, Vellore, India
- 773 0_
- $t Journal of applied biomedicine $x 1214-021X $g Roč. 18, č. 2-3 (2020), s. 87-95 $w MED00012667
- 856 41
- $u https://jab.zsf.jcu.cz/pdfs/jab/2020/02/08.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y p $z 0
- 990 __
- $a 20201102142735 $b ABA008
- 991 __
- $a 20210417153243 $b ABA008
- 999 __
- $a ok $b bmc $g 1578925 $s 1107480
- BAS __
- $a 3
- BMC __
- $a 2020 $b 18 $c 2-3 $d 87-95 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
- LZP __
- $c NLK197 $d 20210417 $a NLK 2020-40/dk